Sign in
4

Changes in Ownership

Amphastar Pharmaceuticals, Inc. Filed Acc 0001415889-24-007367

CFO, EVP & TREASURER sold 18,136 shares at an average $46.48 ($842,883)

  • CFO, EVP & TREASURER gave up 2,190 shares (to pay taxes)
  • CFO, EVP & TREASURER acquired 8,826 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Option exercise 10b5-1 +8,826 $11.33 $99,999 129,626 D
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Sale 10b5-1 −13,404 $46.30 $620,540 116,222 D
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Sale 10b5-1 −4,681 $46.98 $219,896 111,541 D
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Sale 10b5-1 −51 $48.00 $2,448 111,490 D
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Shares withheld for taxes 10b5-1 −2,190 $46.31 $101,419 109,300 D
Derivatives
PETERS WILLIAM J CFO, EVP & TREASURER 2024-03-06 Option exercise · Employee Stock Option (right to buy) 10b5-1 −8,826 0 D
Open-market sales · 18,136 sh · avg $46.48 · $842,883
Loading xslF345X05/form4-03082024_090331.xml…